Literature DB >> 30132234

Overview of this issue: pharmacovigilance, what is new?

Linda Gore Martin1, Yolande Hanssens2, Vibhu Paudyal3.   

Abstract

Mesh：

Year:  2018        PMID： 30132234     DOI： 10.1007/s11096-018-0719-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  30 in total

1.  Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension.

Authors:  Marie-Camille Chaumais; Caroline O'Connell; Laurent Savale; Christophe Guignabert; Frédéric Perros; Xavier Jaïs; Olivier Sitbon; Marc Humbert; David Montani
Journal:  Int J Clin Pharm       Date:  2018-08-13

2.  Potential negative impact of informing patients about medication side effects: a systematic review.

Authors:  Jimmy Jose; Lamia AlHajri
Journal:  Int J Clin Pharm       Date:  2018-08-23

3.  Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database.

Authors:  Ying Zhao; Haidong Lu; Sydney Thai; Xiaotong Li; John Hui; Huilin Tang; Suodi Zhai; Lulu Sun; Tiansheng Wang
Journal:  Int J Clin Pharm       Date:  2018-02-20

4.  Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone.

Authors:  Jun-Hong Ye; Yunn-Fang Ho; Angela W-F On; Wen-Wen Chen; Yen-Ming Huang; Wei-I Huang; Yun-Wen Tang
Journal:  Int J Clin Pharm       Date:  2018-07-26

5.  The role and strategy of ISoP in global pharmacovigilance.

Authors:  Sten Olsson; Mira Harrison-Woolrych
Journal:  Int J Clin Pharm       Date:  2018-08-02

6.  Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals.

Authors:  Anna Laven; Katharina Schmitz; Wilhelm-Hubertus Franzen
Journal:  Int J Clin Pharm       Date:  2018-06-16

7.  Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar.

Authors:  Moza Al Hail; Wessam Elkassem; Anas Hamad; Pallivalappila Abdulrouf; Binny Thomas; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2018-04-03

8.  Using a cancer registry to capture signals of adverse events following immune and targeted therapy for melanoma.

Authors:  João P Aguiar; Fábio Cardoso Borges; Rodrigo Murteira; Catarina Ramos; Emanuel Gouveia; Maria José Passos; Ana Miranda; Filipa Alves da Costa
Journal:  Int J Clin Pharm       Date:  2018-06-02

9.  Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.

Authors:  Raymond Li; Colin Curtain; Luke Bereznicki; Syed Tabish Razi Zaidi
Journal:  Int J Clin Pharm       Date:  2018-08-10

Review 10.  Pharmacovigilance in oncology.

Authors:  Paolo Baldo; Giulia Fornasier; Laura Ciolfi; Ivana Sartor; Sara Francescon
Journal:  Int J Clin Pharm       Date:  2018-08-01
View more
  1 in total

1.  Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.

Authors:  Lucas Kosobuski; Andrew Hawn; Katelyn France; Nathaniel Chen; Cierra LaPlante; Laura Palombi
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.